Catalyst Biosciences Growth, Revenue, Number of Employees and Funding

Overview

Location:
Total Funding:$94.3M
Industry:Biotech
Founded:N/A
Lead Investor(s):JonesTrading Institutional Services LLC
Press

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Catalyst Biosciences's estimated revenue is currently $0M per year.
  • Catalyst Biosciences received $115.0M in venture funding in February 2018.
  • Catalyst Biosciences's estimated revenue per employee is $122
  • Catalyst Biosciences's total funding is $94.3M.

Employee Data

  • Catalyst Biosciences has 49 Employees.
  • Catalyst Biosciences grew their employee count by 20% last year.
  • Catalyst Biosciences currently has 9 job openings.

Executive Contacts

NameTitle
Jen WilsonDirector, Project Management
Janet HillmanSenior Director Project Management
Veronica CaiSenior Director, Controller
Eddie WilliamsBoard of Directors
Arwa ShurrabVice President
Faisal ShawwaExecutive Director Finance & Senior Controller
Andy HoweSr Director Quality Assurance
Andrew HetheringtonSVP Technical Operations
Rene AlvarezDirector, Medical Writing
Frank BoothConsultant Clinical Development Director

What Is Catalyst Biosciences?

Catalyst is focused on developing novel medicines to address serious medical conditions for patients who need new or better treatment options. We used a scientific approach focused on protease-based therapeutic candidates to build a clinical-stage biopharmaceutical company whose current mission is to develop valuable therapies for patients with hemophilia. Learn more about Our Hemophilia Program. A protease is an enzyme that cleaves target proteins. Learn more about Proteases.

keywords:Biotechnology,Cleantech,Healthcare,Pharmaceuticals,Wind Power

49

Number of Employees

$0M

Revenue (est)

9

Current Jobs

20%

Employee Growth %

$94.3M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
DiaCarta
$6.2M4310%$53M
Mission Bio
$10.7M7445%
Rigel Pharmaceu...
$42M2904%
ProTrials Resea...
$26.4M1823%
Trace Genomics
$5.9M4137%
Advanced Cell D...
$25.7M1788%
CellMax Life
$5.7M4011%$9M
Vaxart
$4.2M33-15%$58.6M
Full Spectrum A...
$6M425%
Calysta
$7.1M49-2%

Catalyst Biosciences News

09/03/2019 - Catalyst Biosciences to Present at the 2019 ASBMB ...

Catalyst Biosciences to Present at the 2019 ASBMB Symposium on Serine Proteases in Pericellular Proteolysis and Signaling Conference ...

09/08/2019 - Catalyst Biosciences to Present at the 2019 Hemophilia Drug ...

SOUTH SAN FRANCISCO, Calif., Aug. 16, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), today announced an oral ...

09/03/2019 - Catalyst Biosciences Announces Transition of Chief Financial ...

SOUTH SAN FRANCISCO, Calif., Aug. 29, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), today announced that its ...

Catalyst Biosciences Funding

DateAmountRoundLead InvestorsReference
2004-10-29$10.3MASofinnova VeArticle
2006-02-10$30.0MBMorgenthaler VenturesArticle
2008-12-04$40.4MCEssex Woodlands Health VentureArticle
2012-01-09$7.0MUndisclosedPfizerArticle
2017-04-10$20.7MUndisclosedLadenburg Thalmann & Co. IncArticle
2017-12-22$10.5MUndisclosedJonesTrading Institutional Services LLCArticle
2018-02-14$115.0MUndisclosedJonesTrading Institutional Services LLCArticle

Catalyst Biosciences Executive Hires

DateNameTitleReference
2005-03-09Title: David J. O'ReillyPresidentArticle
2006-02-13Edwin MadisonChief Scientific OfficerArticle
2006-02-23Nassim UsmanCEOArticle
2006-05-24Marc NavreVP Drug DiscoveryArticle
2007-02-02Erik WibergChief Financial OfficerArticle
2008-10-29Todd LorenzChief Medical OfficerArticle
2010-03-03William J. DawsonCFOArticle
2017-02-17Andrew HetheringtonSVP Technical OperationsArticle

Catalyst Biosciences Staff Cuts

DateNumber of EmployeesLocationReference
2016-09-0810Article